






{"id":1089,"date":"2025-11-14T15:21:13","date_gmt":"2025-11-14T15:21:13","guid":{"rendered":"https:\/\/novacoremuldev.wpengine.com\/carbon\/?page_id=1089"},"modified":"2025-12-09T03:43:20","modified_gmt":"2025-12-09T03:43:20","slug":"news","status":"publish","type":"page","link":"https:\/\/novacore.com\/carbon\/news\/","title":{"rendered":"News"},"content":{"rendered":"<!--themify_builder_content-->\n<div id=\"themify_builder_content-1089\" data-postid=\"1089\" class=\"themify_builder_content themify_builder_content-1089 themify_builder tf_clear\">\n                    <div  data-css_id=\"62rr462\" data-lazy=\"1\" class=\"module_row themify_builder_row fullwidth_row_container tb_62rr462 tb_first tf_w\">\n            <span  class=\"builder_row_cover tf_abs\" data-lazy=\"1\"><\/span>            <div class=\"row_inner col_align_top tb_col_count_1 tf_box tf_rel\">\n                        <div  data-lazy=\"1\" class=\"module_column tb-column col-full tb_18st462 first\">\n                    <!-- module text -->\n<div  class=\"module module-text tb_5h8v462   \" data-lazy=\"1\">\n        <div  class=\"tb_text_wrap\">\n        <h1 style=\"text-align: center;\">News<\/h1><h2 style=\"font-size: 26px; line-height: 150%; text-align: center;\"><span style=\"font-weight: 400;\">Get the latest market insights<\/span><\/h2>    <\/div>\n<\/div>\n<!-- \/module text -->        <\/div>\n                        <\/div>\n        <\/div>\n                        <div  data-lazy=\"1\" class=\"module_row themify_builder_row tb_b0sh462 tf_w\">\n                        <div class=\"row_inner col_align_top tb_col_count_1 tf_box tf_rel\">\n                        <div  data-lazy=\"1\" class=\"module_column tb-column col-full tb_3n5r462 first\">\n                    <!-- module text -->\n<div  class=\"module module-text tb_ucoj462   \" data-lazy=\"1\">\n        <div  class=\"tb_text_wrap\">\n        <p style=\"text-align: center;\">Stay up to date with Carbon\u2019s expert perspectives, company news and the latest on the pipeline of novel cell and gene therapies that present profound financial implications for payors.<\/p><p style=\"text-align: center;\">Follow us on\u00a0<a href=\"https:\/\/www.linkedin.com\/company\/carbon-stoploss\/\" target=\"_blank\" rel=\"noopener\">LinkedIn<\/a>\u00a0for ongoing updates.<\/p>    <\/div>\n<\/div>\n<!-- \/module text -->        <\/div>\n                        <\/div>\n        <\/div>\n                        <div  data-lazy=\"1\" class=\"module_row themify_builder_row tb_9dml462 tf_w\">\n                        <div class=\"row_inner col_align_top tb_col_count_1 tf_box tf_rel\">\n                        <div  data-lazy=\"1\" class=\"module_column tb-column col-full tb_ahh8462 first\">\n                    <!-- module plain text -->\n<div  class=\"module module-plain-text tb_7oqi462 \" data-lazy=\"1\">\n        <div class=\"tb_text_wrap\">\n    \n        <style>\n        .ngp-archive-wrapper .gridpost-filters label {\n            background: #f6f6f6;\n            color: #000000;\n        }\n        .ngp-archive-wrapper .gridpost-filters label.active,\n        .ngp-archive-wrapper .gridpost-filters label:hover {\n            background: #2B63AC;\n            color: #ffffff;\n        }\n        .ngp-archive-wrapper .gridpost-card {\n            background: #ffffff;\n            border-radius: 16px;\n            border: none;\n            box-shadow: 0px 12px 52px 0px rgba(43, 99, 172, 0.25);\n        }\n        .ngp-archive-wrapper .gridpost-card .tbp_title a {\n            color: #000000;\n        }\n        .ngp-archive-wrapper .gridpost-card:hover .tbp_title a {\n            color: #2B63AC;\n        }\n        .ngp-archive-wrapper .gridpost-card .excerpt {\n            color: #00273d;\n        }\n        .ngp-archive-wrapper .gridpost-card:hover {\n            box-shadow: 0px 16px 56px 0px rgba(43, 99, 172, 0.25);\n        }\n        \n        \/* Pagination Styles *\/\n        .ngp-pagination.pagenav .current {\n            color: #ffffff;\n            background-color: #d100ce;\n        }\n        .ngp-pagination.pagenav a {\n            color: #d100ce;\n        }\n        \/*.ngp-pagination.pagenav a:hover {\n            color: #ffffff;\n        }*\/\n\n        \/* Load More Button Styles *\/\n        .ngp-load-more {\n            background-color: #00273d;\n            color: #ffffff;\n        }\n        .ngp-load-more:hover {\n            background-color: #2b63ac;\n            color: #ffffff;\n        }\n        <\/style>\n        <div class=\"gridposts-archive-wrapper ngp-archive-wrapper\">\n\n            \n            <div id=\"ngp-grid\" class=\"masonry-grid\">\n                <div class=\"grid-sizer\"><\/div>\n                <div class=\"gutter-sizer\"><\/div>\n\n                            <article class=\"gridpost-card carbon\">\n                <div class=\"card-inner\">\n                                            <a class=\"thumb\" href=\"https:\/\/investor.regeneron.com\/news-releases\/news-release-details\/otarmenitm-lunsotogene-parvec-cwha-approved-fda-first-and-only\" target=\"_blank\">\n                            <img decoding=\"async\" width=\"800\" height=\"419\" src=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2026\/05\/CarbonFDA_Graphic2.png\" class=\"attachment-large size-large wp-post-image\" alt=\"Digital render of cells splitting\" loading=\"lazy\" srcset=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2026\/05\/CarbonFDA_Graphic2.png 800w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2026\/05\/CarbonFDA_Graphic2-300x157.png 300w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2026\/05\/CarbonFDA_Graphic2-768x402.png 768w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2026\/05\/CarbonFDA_Graphic2-1024x536.png 1024w\" sizes=\"auto, (max-width: 800px) 100vw, 800px\" \/>                        <\/a>\n                                        <div class=\"gridpost-body\">\n                        <h3 class=\"tbp_title\">\n                            <a href=\"https:\/\/investor.regeneron.com\/news-releases\/news-release-details\/otarmenitm-lunsotogene-parvec-cwha-approved-fda-first-and-only\" target=\"_blank\">Otarmeni\u2122\ufe0f (lunsotogene parvec-cwha) Approved by FDA<\/a>\n                        <\/h3>\n                                                    <p class=\"excerpt\">Otarmeni\u2122\ufe0f (lunsotogene parvec-cwha) Approved by FDA as First and Only Gene Therapy for Genetic Hearing Loss; Regeneron to Provide Otarmeni for Free in the&hellip;<\/p>\n                        \n                                                    <p>\n                                <a class=\"read-more\" href=\"https:\/\/investor.regeneron.com\/news-releases\/news-release-details\/otarmenitm-lunsotogene-parvec-cwha-approved-fda-first-and-only\" target=\"_blank\">\n                                    Read more                                <\/a>\n                            <\/p>\n                                            <\/div>\n                <\/div>\n            <\/article>\n                        <article class=\"gridpost-card carbon\">\n                <div class=\"card-inner\">\n                                            <a class=\"thumb\" href=\"https:\/\/ir.rocketpharma.com\/news-releases\/news-release-details\/rocket-pharmaceuticals-announces-fda-approval-kresladitm\" target=\"_blank\">\n                            <img decoding=\"async\" width=\"800\" height=\"419\" src=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2026\/05\/CarbonFDA_Graphic.png\" class=\"attachment-large size-large wp-post-image\" alt=\"Graphic with text, FDA Approved\" loading=\"lazy\" srcset=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2026\/05\/CarbonFDA_Graphic.png 800w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2026\/05\/CarbonFDA_Graphic-300x157.png 300w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2026\/05\/CarbonFDA_Graphic-768x402.png 768w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2026\/05\/CarbonFDA_Graphic-1024x536.png 1024w\" sizes=\"auto, (max-width: 800px) 100vw, 800px\" \/>                        <\/a>\n                                        <div class=\"gridpost-body\">\n                        <h3 class=\"tbp_title\">\n                            <a href=\"https:\/\/ir.rocketpharma.com\/news-releases\/news-release-details\/rocket-pharmaceuticals-announces-fda-approval-kresladitm\" target=\"_blank\">Rocket Pharmaceuticals Announces FDA Approval of KRESLADI\u2122\ufe0f<\/a>\n                        <\/h3>\n                                                    <p class=\"excerpt\">Rocket Pharmaceuticals Announces FDA Approval of KRESLADI\u2122\ufe0f for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I) Read Full Story &nbsp;<\/p>\n                        \n                                                    <p>\n                                <a class=\"read-more\" href=\"https:\/\/ir.rocketpharma.com\/news-releases\/news-release-details\/rocket-pharmaceuticals-announces-fda-approval-kresladitm\" target=\"_blank\">\n                                    Read more                                <\/a>\n                            <\/p>\n                                            <\/div>\n                <\/div>\n            <\/article>\n                        <article class=\"gridpost-card carbon\">\n                <div class=\"card-inner\">\n                                            <a class=\"thumb\" href=\"https:\/\/novacore.com\/carbon-stop-loss-hires-rga-managed-care-team\/\" target=\"_self\">\n                            <img decoding=\"async\" width=\"800\" height=\"600\" src=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2026\/02\/0226_Carbon_News_RGA-Team.jpg\" class=\"attachment-large size-large wp-post-image\" alt=\"Photo of stethoscope with digital overlay of health data and text: Announcement\" loading=\"lazy\" srcset=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2026\/02\/0226_Carbon_News_RGA-Team.jpg 800w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2026\/02\/0226_Carbon_News_RGA-Team-300x225.jpg 300w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2026\/02\/0226_Carbon_News_RGA-Team-768x576.jpg 768w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2026\/02\/0226_Carbon_News_RGA-Team-1024x768.jpg 1024w\" sizes=\"auto, (max-width: 800px) 100vw, 800px\" \/>                        <\/a>\n                                        <div class=\"gridpost-body\">\n                        <h3 class=\"tbp_title\">\n                            <a href=\"https:\/\/novacore.com\/carbon-stop-loss-hires-rga-managed-care-team\/\" target=\"_self\">Carbon Expands Managed Care Team with RGA Veterans<\/a>\n                        <\/h3>\n                                                    <p class=\"excerpt\">Carbon expands its managed care division with veteran industry talent, deepening underwriting and actuarial expertise. CONSHOHOCKEN, PA, February 23, 2026 \u2013 Carbon Stop Loss&hellip;<\/p>\n                        \n                                                    <p>\n                                <a class=\"read-more\" href=\"https:\/\/novacore.com\/carbon-stop-loss-hires-rga-managed-care-team\/\" target=\"_self\">\n                                    Read more                                <\/a>\n                            <\/p>\n                                            <\/div>\n                <\/div>\n            <\/article>\n                        <article class=\"gridpost-card carbon\">\n                <div class=\"card-inner\">\n                                            <a class=\"thumb\" href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-gene-therapy-treatment-wiskott-aldrich-syndrome#:~:text=FDA%20Approves%20First%20Gene%20Therapy%20Treatment%20for%20Wiskott-Aldrich%20Syndrome,-Agency%20exercises%20regulatory&#038;text=The%20U.S.%20Food%20and%20Drug,-Aldrich%20syndrome%20(WAS)\" target=\"_blank\">\n                            <img decoding=\"async\" width=\"1000\" height=\"556\" src=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/12\/Cells.jpg\" class=\"attachment-large size-large wp-post-image\" alt=\"Digital render of cells interacting\" loading=\"lazy\" srcset=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/12\/Cells.jpg 1000w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/12\/Cells-300x167.jpg 300w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/12\/Cells-768x427.jpg 768w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/12\/Cells-1024x569.jpg 1024w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/12\/Cells-321x178.jpg 321w\" sizes=\"auto, (max-width: 1000px) 100vw, 1000px\" \/>                        <\/a>\n                                        <div class=\"gridpost-body\">\n                        <h3 class=\"tbp_title\">\n                            <a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-gene-therapy-treatment-wiskott-aldrich-syndrome#:~:text=FDA%20Approves%20First%20Gene%20Therapy%20Treatment%20for%20Wiskott-Aldrich%20Syndrome,-Agency%20exercises%20regulatory&#038;text=The%20U.S.%20Food%20and%20Drug,-Aldrich%20syndrome%20(WAS)\" target=\"_blank\">FDA Approves First Gene Therapy Treatment for Wiskott-Aldrich Syndrome<\/a>\n                        <\/h3>\n                                                    <p class=\"excerpt\">For Australian biotech Mesoblast, it took three go-rounds with the FDA to win approval of Ryoncil, a cell therapy for graft versus host disease.<\/p>\n                        \n                                                    <p>\n                                <a class=\"read-more\" href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-gene-therapy-treatment-wiskott-aldrich-syndrome#:~:text=FDA%20Approves%20First%20Gene%20Therapy%20Treatment%20for%20Wiskott-Aldrich%20Syndrome,-Agency%20exercises%20regulatory&#038;text=The%20U.S.%20Food%20and%20Drug,-Aldrich%20syndrome%20(WAS)\" target=\"_blank\">\n                                    Read more                                <\/a>\n                            <\/p>\n                                            <\/div>\n                <\/div>\n            <\/article>\n                        <article class=\"gridpost-card carbon\">\n                <div class=\"card-inner\">\n                                            <a class=\"thumb\" href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-cellular-therapy-treat-patients-severe-aplastic-anemia#:~:text=The%20U.S.%20Food%20and%20Drug,white%20blood%20cells%20and%20platelets\" target=\"_blank\">\n                            <img decoding=\"async\" width=\"1000\" height=\"667\" src=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/12\/AdobeStock_658161566.jpeg\" class=\"attachment-large size-large wp-post-image\" alt=\"Female drug lab worker\" loading=\"lazy\" srcset=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/12\/AdobeStock_658161566.jpeg 1000w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/12\/AdobeStock_658161566-300x200.jpeg 300w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/12\/AdobeStock_658161566-768x512.jpeg 768w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/12\/AdobeStock_658161566-1024x683.jpeg 1024w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/12\/AdobeStock_658161566-321x214.jpeg 321w\" sizes=\"auto, (max-width: 1000px) 100vw, 1000px\" \/>                        <\/a>\n                                        <div class=\"gridpost-body\">\n                        <h3 class=\"tbp_title\">\n                            <a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-cellular-therapy-treat-patients-severe-aplastic-anemia#:~:text=The%20U.S.%20Food%20and%20Drug,white%20blood%20cells%20and%20platelets\" target=\"_blank\">FDA Approves First Cellular Therapy to Treat Patients with Severe Aplastic Anemia<\/a>\n                        <\/h3>\n                                                    <p class=\"excerpt\">For Australian biotech Mesoblast, it took three go-rounds with the FDA to win approval of Ryoncil, a cell therapy for graft versus host disease.<\/p>\n                        \n                                                    <p>\n                                <a class=\"read-more\" href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-cellular-therapy-treat-patients-severe-aplastic-anemia#:~:text=The%20U.S.%20Food%20and%20Drug,white%20blood%20cells%20and%20platelets\" target=\"_blank\">\n                                    Read more                                <\/a>\n                            <\/p>\n                                            <\/div>\n                <\/div>\n            <\/article>\n                        <article class=\"gridpost-card carbon\">\n                <div class=\"card-inner\">\n                                            <a class=\"thumb\" href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-car-t-cell-therapy-marginal-zone-lymphoma-us\" target=\"_blank\">\n                            <img decoding=\"async\" width=\"1000\" height=\"544\" src=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/12\/AdobeStock_516172844.jpeg\" class=\"attachment-large size-large wp-post-image\" alt=\"Hand holding a syringe with the letters FDA\" loading=\"lazy\" srcset=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/12\/AdobeStock_516172844.jpeg 1000w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/12\/AdobeStock_516172844-300x163.jpeg 300w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/12\/AdobeStock_516172844-768x418.jpeg 768w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/12\/AdobeStock_516172844-1024x557.jpeg 1024w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/12\/AdobeStock_516172844-321x174.jpeg 321w\" sizes=\"auto, (max-width: 1000px) 100vw, 1000px\" \/>                        <\/a>\n                                        <div class=\"gridpost-body\">\n                        <h3 class=\"tbp_title\">\n                            <a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-car-t-cell-therapy-marginal-zone-lymphoma-us\" target=\"_blank\">FDA Approves First CAR T-Cell Therapy for Marginal Zone Lymphoma In the US<\/a>\n                        <\/h3>\n                                                    <p class=\"excerpt\">For Australian biotech Mesoblast, it took three go-rounds with the FDA to win approval of Ryoncil, a cell therapy for graft versus host disease.<\/p>\n                        \n                                                    <p>\n                                <a class=\"read-more\" href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-car-t-cell-therapy-marginal-zone-lymphoma-us\" target=\"_blank\">\n                                    Read more                                <\/a>\n                            <\/p>\n                                            <\/div>\n                <\/div>\n            <\/article>\n                        <article class=\"gridpost-card carbon\">\n                <div class=\"card-inner\">\n                                            <a class=\"thumb\" href=\"https:\/\/issuu.com\/selfinsurer\/docs\/march_2025_the_self-insurer?fr=sYjgyMjYzMzE2NzM\" target=\"_blank\">\n                            <img decoding=\"async\" width=\"400\" height=\"300\" src=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/0325_CarbonNews_SelfInsurer-400x300-1.png\" class=\"attachment-large size-large wp-post-image\" alt=\"\" loading=\"lazy\" srcset=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/0325_CarbonNews_SelfInsurer-400x300-1.png 400w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/0325_CarbonNews_SelfInsurer-400x300-1-300x225.png 300w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/0325_CarbonNews_SelfInsurer-400x300-1-1024x768.png 1024w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/0325_CarbonNews_SelfInsurer-400x300-1-321x240.png 321w\" sizes=\"auto, (max-width: 400px) 100vw, 400px\" \/>                        <\/a>\n                                        <div class=\"gridpost-body\">\n                        <h3 class=\"tbp_title\">\n                            <a href=\"https:\/\/issuu.com\/selfinsurer\/docs\/march_2025_the_self-insurer?fr=sYjgyMjYzMzE2NzM\" target=\"_blank\">Growth of Value-Based Purchasing For Cell &#038; Gene Therapies<\/a>\n                        <\/h3>\n                                                    <p class=\"excerpt\">Rx Data Reporting Stops Short of Price Transparency PBMs find a way around CMS requirement meant to prevent hidden rebates<\/p>\n                        \n                                                    <p>\n                                <a class=\"read-more\" href=\"https:\/\/issuu.com\/selfinsurer\/docs\/march_2025_the_self-insurer?fr=sYjgyMjYzMzE2NzM\" target=\"_blank\">\n                                    Read more                                <\/a>\n                            <\/p>\n                                            <\/div>\n                <\/div>\n            <\/article>\n                        <article class=\"gridpost-card carbon\">\n                <div class=\"card-inner\">\n                                            <a class=\"thumb\" href=\"https:\/\/www.fiercepharma.com\/pharma\/fda-nod-gvhd-cell-therapy-gives-australian-biotech-mesoblast\" target=\"_blank\">\n                            <img decoding=\"async\" width=\"850\" height=\"478\" src=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/GettyImages-512294717.webp\" class=\"attachment-large size-large wp-post-image\" alt=\"\" loading=\"lazy\" srcset=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/GettyImages-512294717.webp 850w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/GettyImages-512294717-300x169.webp 300w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/GettyImages-512294717-768x432.webp 768w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/GettyImages-512294717-1024x575.webp 1024w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/GettyImages-512294717-321x180.webp 321w\" sizes=\"auto, (max-width: 850px) 100vw, 850px\" \/>                        <\/a>\n                                        <div class=\"gridpost-body\">\n                        <h3 class=\"tbp_title\">\n                            <a href=\"https:\/\/www.fiercepharma.com\/pharma\/fda-nod-gvhd-cell-therapy-gives-australian-biotech-mesoblast\" target=\"_blank\">FDA Approves Mesoblast\u2019s First-Of-Its-Kind Cell Therapy<\/a>\n                        <\/h3>\n                                                    <p class=\"excerpt\">For Australian biotech Mesoblast, it took three go-rounds with the FDA to win approval of Ryoncil, a cell therapy for graft versus host disease.<\/p>\n                        \n                                                    <p>\n                                <a class=\"read-more\" href=\"https:\/\/www.fiercepharma.com\/pharma\/fda-nod-gvhd-cell-therapy-gives-australian-biotech-mesoblast\" target=\"_blank\">\n                                    Read more                                <\/a>\n                            <\/p>\n                                            <\/div>\n                <\/div>\n            <\/article>\n                        <article class=\"gridpost-card carbon\">\n                <div class=\"card-inner\">\n                                            <a class=\"thumb\" href=\"https:\/\/www.fiercepharma.com\/pharma\/first-brain-delivered-gene-therapy-hits-us-ptc-therapeutics-aadc-deficiency-treatment\" target=\"_blank\">\n                            <img decoding=\"async\" width=\"850\" height=\"478\" src=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/GettyImages-1398639598.webp\" class=\"attachment-large size-large wp-post-image\" alt=\"\" loading=\"lazy\" srcset=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/GettyImages-1398639598.webp 850w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/GettyImages-1398639598-300x169.webp 300w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/GettyImages-1398639598-768x432.webp 768w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/GettyImages-1398639598-1024x575.webp 1024w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/GettyImages-1398639598-321x180.webp 321w\" sizes=\"auto, (max-width: 850px) 100vw, 850px\" \/>                        <\/a>\n                                        <div class=\"gridpost-body\">\n                        <h3 class=\"tbp_title\">\n                            <a href=\"https:\/\/www.fiercepharma.com\/pharma\/first-brain-delivered-gene-therapy-hits-us-ptc-therapeutics-aadc-deficiency-treatment\" target=\"_blank\">PTC Wins FDA Approval For First Brain-Delivered Gene Therapy Kebilidi<\/a>\n                        <\/h3>\n                                                    <p class=\"excerpt\">Kebilidi represents the 13th gene therapy to score an FDA nod, but it&#039;s the first gene therapy to be administered directly in the brain.<\/p>\n                        \n                                                    <p>\n                                <a class=\"read-more\" href=\"https:\/\/www.fiercepharma.com\/pharma\/first-brain-delivered-gene-therapy-hits-us-ptc-therapeutics-aadc-deficiency-treatment\" target=\"_blank\">\n                                    Read more                                <\/a>\n                            <\/p>\n                                            <\/div>\n                <\/div>\n            <\/article>\n                        <article class=\"gridpost-card carbon\">\n                <div class=\"card-inner\">\n                                            <a class=\"thumb\" href=\"https:\/\/www.managedhealthcareexecutive.com\/view\/fda-approves-aucatzyl-for-adults-with-aggressive-leukemia\" target=\"_blank\">\n                            <img decoding=\"async\" width=\"400\" height=\"300\" src=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2024\/11\/37_CarbonNews_Autolus.png\" class=\"attachment-large size-large wp-post-image\" alt=\"\" loading=\"lazy\" srcset=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2024\/11\/37_CarbonNews_Autolus.png 400w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2024\/11\/37_CarbonNews_Autolus-300x225.png 300w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2024\/11\/37_CarbonNews_Autolus-1024x768.png 1024w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2024\/11\/37_CarbonNews_Autolus-321x240.png 321w\" sizes=\"auto, (max-width: 400px) 100vw, 400px\" \/>                        <\/a>\n                                        <div class=\"gridpost-body\">\n                        <h3 class=\"tbp_title\">\n                            <a href=\"https:\/\/www.managedhealthcareexecutive.com\/view\/fda-approves-aucatzyl-for-adults-with-aggressive-leukemia\" target=\"_blank\">FDA Approves Aucatzyl for Adults with Aggressive Leukemia<\/a>\n                        <\/h3>\n                                                    <p class=\"excerpt\">Aucatzyl is a CAR T-cell therapy that targets CD19 and has been designed to minimize excessive activation of the programmed T cells. The wholesale&hellip;<\/p>\n                        \n                                                    <p>\n                                <a class=\"read-more\" href=\"https:\/\/www.managedhealthcareexecutive.com\/view\/fda-approves-aucatzyl-for-adults-with-aggressive-leukemia\" target=\"_blank\">\n                                    Read more                                <\/a>\n                            <\/p>\n                                            <\/div>\n                <\/div>\n            <\/article>\n                        <article class=\"gridpost-card news\">\n                <div class=\"card-inner\">\n                                            <a class=\"thumb\" href=\"https:\/\/novacore.com\/sequoia-ioa-re-and-rockport-benefits-form-carbon-stop-loss-solutions\/\" target=\"_self\">\n                            <img decoding=\"async\" width=\"400\" height=\"300\" src=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2024\/08\/2_CarbonNews_Carbon.png\" class=\"attachment-large size-large wp-post-image\" alt=\"\" loading=\"lazy\" srcset=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2024\/08\/2_CarbonNews_Carbon.png 400w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2024\/08\/2_CarbonNews_Carbon-300x225.png 300w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2024\/08\/2_CarbonNews_Carbon-321x240.png 321w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2024\/08\/2_CarbonNews_Carbon-1024x768.png 1024w\" sizes=\"auto, (max-width: 400px) 100vw, 400px\" \/>                        <\/a>\n                                        <div class=\"gridpost-body\">\n                        <h3 class=\"tbp_title\">\n                            <a href=\"https:\/\/novacore.com\/sequoia-ioa-re-and-rockport-benefits-form-carbon-stop-loss-solutions\/\" target=\"_self\">Sequoia, IOA Re and Rockport Benefits Form Carbon Stop Loss Solutions<\/a>\n                        <\/h3>\n                                                    <p class=\"excerpt\">New singular brand spotlights innovative\u00a0employer stop loss and managed care offerings\u00a0that are stronger by design CONSHOHOCKEN, PA, August 28, 2024 \u2013\u00a0Sequoia Reinsurance Services, IOA&hellip;<\/p>\n                        \n                                                    <p>\n                                <a class=\"read-more\" href=\"https:\/\/novacore.com\/sequoia-ioa-re-and-rockport-benefits-form-carbon-stop-loss-solutions\/\" target=\"_self\">\n                                    Read more                                <\/a>\n                            <\/p>\n                                            <\/div>\n                <\/div>\n            <\/article>\n                        <article class=\"gridpost-card carbon\">\n                <div class=\"card-inner\">\n                                            <a class=\"thumb\" href=\"https:\/\/www.fiercepharma.com\/pharma\/adaptimmune-scores-fda-nod-first-engineered-cell-therapy-solid-tumor\" target=\"_blank\">\n                            <img decoding=\"async\" width=\"850\" height=\"478\" src=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/SARCOMA.webp\" class=\"attachment-large size-large wp-post-image\" alt=\"\" loading=\"lazy\" srcset=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/SARCOMA.webp 850w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/SARCOMA-300x169.webp 300w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/SARCOMA-768x432.webp 768w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/SARCOMA-1024x575.webp 1024w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/SARCOMA-321x180.webp 321w\" sizes=\"auto, (max-width: 850px) 100vw, 850px\" \/>                        <\/a>\n                                        <div class=\"gridpost-body\">\n                        <h3 class=\"tbp_title\">\n                            <a href=\"https:\/\/www.fiercepharma.com\/pharma\/adaptimmune-scores-fda-nod-first-engineered-cell-therapy-solid-tumor\" target=\"_blank\">FDA Signs Off on Adaptimmune\u2019s Tecelra<\/a>\n                        <\/h3>\n                                                    <p class=\"excerpt\">Patients with a certain type of synovial sarcoma have a new treatment option for the first time in more than a decade as the&hellip;<\/p>\n                        \n                                                    <p>\n                                <a class=\"read-more\" href=\"https:\/\/www.fiercepharma.com\/pharma\/adaptimmune-scores-fda-nod-first-engineered-cell-therapy-solid-tumor\" target=\"_blank\">\n                                    Read more                                <\/a>\n                            <\/p>\n                                            <\/div>\n                <\/div>\n            <\/article>\n                        <article class=\"gridpost-card carbon\">\n                <div class=\"card-inner\">\n                                            <a class=\"thumb\" href=\"https:\/\/novacore.com\/overcoming-vulnerabilities-for-stewards-of-member-health-data\/\" target=\"_self\">\n                            <img decoding=\"async\" width=\"850\" height=\"478\" src=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/SARCOMA-1.webp\" class=\"attachment-large size-large wp-post-image\" alt=\"\" loading=\"lazy\" srcset=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/SARCOMA-1.webp 850w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/SARCOMA-1-300x169.webp 300w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/SARCOMA-1-768x432.webp 768w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/SARCOMA-1-1024x575.webp 1024w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/SARCOMA-1-321x180.webp 321w\" sizes=\"auto, (max-width: 850px) 100vw, 850px\" \/>                        <\/a>\n                                        <div class=\"gridpost-body\">\n                        <h3 class=\"tbp_title\">\n                            <a href=\"https:\/\/novacore.com\/overcoming-vulnerabilities-for-stewards-of-member-health-data\/\" target=\"_self\">Overcoming Vulnerabilities For Stewards of Member Health Data<\/a>\n                        <\/h3>\n                                                    <p class=\"excerpt\">As cybercriminals target valuable health and personal data, cyberattacks are a growing threat for healthcare organizations and self-insured companies. In a feature article for\u00a0The&hellip;<\/p>\n                        \n                                                    <p>\n                                <a class=\"read-more\" href=\"https:\/\/novacore.com\/overcoming-vulnerabilities-for-stewards-of-member-health-data\/\" target=\"_self\">\n                                    Read more                                <\/a>\n                            <\/p>\n                                            <\/div>\n                <\/div>\n            <\/article>\n                        <article class=\"gridpost-card carbon\">\n                <div class=\"card-inner\">\n                                            <a class=\"thumb\" href=\"https:\/\/www.biopharmadive.com\/news\/sarepta-fda-elevidys-expand-approval-duchenne-gene-therapy\/716778\/\" target=\"_blank\">\n                            <img decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/Sarepta_Boston_232-1024x576.webp\" class=\"attachment-large size-large wp-post-image\" alt=\"\" loading=\"lazy\" srcset=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/Sarepta_Boston_232-1024x576.webp 1024w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/Sarepta_Boston_232-300x169.webp 300w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/Sarepta_Boston_232-768x432.webp 768w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/Sarepta_Boston_232-321x180.webp 321w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/Sarepta_Boston_232.webp 1200w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/>                        <\/a>\n                                        <div class=\"gridpost-body\">\n                        <h3 class=\"tbp_title\">\n                            <a href=\"https:\/\/www.biopharmadive.com\/news\/sarepta-fda-elevidys-expand-approval-duchenne-gene-therapy\/716778\/\" target=\"_blank\">Sarepta Duchenne Gene Therapy Wins Broader Use From FDA<\/a>\n                        <\/h3>\n                                                    <p class=\"excerpt\">Despite mixed results in testing, agency officials determined Elevidys showed enough to warrant a label that includes all patients at least 4 years of&hellip;<\/p>\n                        \n                                                    <p>\n                                <a class=\"read-more\" href=\"https:\/\/www.biopharmadive.com\/news\/sarepta-fda-elevidys-expand-approval-duchenne-gene-therapy\/716778\/\" target=\"_blank\">\n                                    Read more                                <\/a>\n                            <\/p>\n                                            <\/div>\n                <\/div>\n            <\/article>\n                        <article class=\"gridpost-card carbon\">\n                <div class=\"card-inner\">\n                                            <a class=\"thumb\" href=\"https:\/\/novacore.com\/the-dangers-cost-of-weight-loss-drugs-how-to-avoid-a-life-sentence\/\" target=\"_self\">\n                            <img decoding=\"async\" width=\"800\" height=\"600\" src=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/6_CarbonNews_JakkiArticleLarger.png\" class=\"attachment-large size-large wp-post-image\" alt=\"\" loading=\"lazy\" srcset=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/6_CarbonNews_JakkiArticleLarger.png 800w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/6_CarbonNews_JakkiArticleLarger-300x225.png 300w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/6_CarbonNews_JakkiArticleLarger-768x576.png 768w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/6_CarbonNews_JakkiArticleLarger-321x240.png 321w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/6_CarbonNews_JakkiArticleLarger-1024x768.png 1024w\" sizes=\"auto, (max-width: 800px) 100vw, 800px\" \/>                        <\/a>\n                                        <div class=\"gridpost-body\">\n                        <h3 class=\"tbp_title\">\n                            <a href=\"https:\/\/novacore.com\/the-dangers-cost-of-weight-loss-drugs-how-to-avoid-a-life-sentence\/\" target=\"_self\">The Dangers, Cost of Weight Loss Drugs \u2014 How to Avoid a Life Sentence<\/a>\n                        <\/h3>\n                                                    <p class=\"excerpt\">Beyond being a major public health challenge, obesity carries extreme implications for employers and their teams. In fact, a recent report estimates obesity cost&hellip;<\/p>\n                        \n                                                    <p>\n                                <a class=\"read-more\" href=\"https:\/\/novacore.com\/the-dangers-cost-of-weight-loss-drugs-how-to-avoid-a-life-sentence\/\" target=\"_self\">\n                                    Read more                                <\/a>\n                            <\/p>\n                                            <\/div>\n                <\/div>\n            <\/article>\n                        <article class=\"gridpost-card carbon\">\n                <div class=\"card-inner\">\n                                            <a class=\"thumb\" href=\"https:\/\/www.fiercepharma.com\/pharma\/bristol-myers-secures-another-fda-go-ahead-breyanzi-time-mantle-cell-lymphoma\" target=\"_blank\">\n                            <img decoding=\"async\" width=\"1\" height=\"1\" src=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/Breyanzi.avif\" class=\"attachment-large size-large wp-post-image\" alt=\"\" loading=\"lazy\" \/>                        <\/a>\n                                        <div class=\"gridpost-body\">\n                        <h3 class=\"tbp_title\">\n                            <a href=\"https:\/\/www.fiercepharma.com\/pharma\/bristol-myers-secures-another-fda-go-ahead-breyanzi-time-mantle-cell-lymphoma\" target=\"_blank\">Bristol Myers Secures Another FDA Go-Ahead For Breyanzi<\/a>\n                        <\/h3>\n                                                    <p class=\"excerpt\">In the years since gaining an initial FDA approval for Breyanzi, Bristol Myers Squibb has worked hard to expand the reach of its cell&hellip;<\/p>\n                        \n                                                    <p>\n                                <a class=\"read-more\" href=\"https:\/\/www.fiercepharma.com\/pharma\/bristol-myers-secures-another-fda-go-ahead-breyanzi-time-mantle-cell-lymphoma\" target=\"_blank\">\n                                    Read more                                <\/a>\n                            <\/p>\n                                            <\/div>\n                <\/div>\n            <\/article>\n                        <article class=\"gridpost-card carbon\">\n                <div class=\"card-inner\">\n                                            <a class=\"thumb\" href=\"https:\/\/www.biospace.com\/bms-s-car-t-therapy-breyanzi-wins-fda-approval-for-expanded-use-in-follicular-lymphoma\" target=\"_blank\">\n                            <img decoding=\"async\" width=\"1000\" height=\"563\" src=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/download.webp\" class=\"attachment-large size-large wp-post-image\" alt=\"\" loading=\"lazy\" srcset=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/download.webp 1000w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/download-300x169.webp 300w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/download-768x432.webp 768w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/download-321x180.webp 321w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/download-1024x576.webp 1024w\" sizes=\"auto, (max-width: 1000px) 100vw, 1000px\" \/>                        <\/a>\n                                        <div class=\"gridpost-body\">\n                        <h3 class=\"tbp_title\">\n                            <a href=\"https:\/\/www.biospace.com\/bms-s-car-t-therapy-breyanzi-wins-fda-approval-for-expanded-use-in-follicular-lymphoma\" target=\"_blank\">BMS CAR-T Therapy Wins FDA Approval for Expanded Use<\/a>\n                        <\/h3>\n                                                    <p class=\"excerpt\">Following back-to-back approvals in lymphocytic leukemia, Bristol Myers Squibb\u2019s CAR-T therapy Breyanzi on Wednesday won the FDA\u2019s green light for relapsed or refractory follicular&hellip;<\/p>\n                        \n                                                    <p>\n                                <a class=\"read-more\" href=\"https:\/\/www.biospace.com\/bms-s-car-t-therapy-breyanzi-wins-fda-approval-for-expanded-use-in-follicular-lymphoma\" target=\"_blank\">\n                                    Read more                                <\/a>\n                            <\/p>\n                                            <\/div>\n                <\/div>\n            <\/article>\n                        <article class=\"gridpost-card carbon\">\n                <div class=\"card-inner\">\n                                            <a class=\"thumb\" href=\"https:\/\/www.fiercepharma.com\/pharma\/pfizer-scores-fda-nod-hemophilia-b-gene-therapy-will-charge-35m-dose\" target=\"_blank\">\n                            <img decoding=\"async\" width=\"850\" height=\"478\" src=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/pfizer.webp\" class=\"attachment-large size-large wp-post-image\" alt=\"\" loading=\"lazy\" srcset=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/pfizer.webp 850w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/pfizer-300x169.webp 300w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/pfizer-768x432.webp 768w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/pfizer-321x180.webp 321w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/pfizer-1024x575.webp 1024w\" sizes=\"auto, (max-width: 850px) 100vw, 850px\" \/>                        <\/a>\n                                        <div class=\"gridpost-body\">\n                        <h3 class=\"tbp_title\">\n                            <a href=\"https:\/\/www.fiercepharma.com\/pharma\/pfizer-scores-fda-nod-hemophilia-b-gene-therapy-will-charge-35m-dose\" target=\"_blank\">Pfizer Will Charge $3.5M For Its First FDA-Approved Gene Therapy<\/a>\n                        <\/h3>\n                                                    <p class=\"excerpt\">Pfizer will offer a warranty program for its first FDA-approved gene therapy. The hemophilia B treatment will go for $3.5M, matching the price tag&hellip;<\/p>\n                        \n                                                    <p>\n                                <a class=\"read-more\" href=\"https:\/\/www.fiercepharma.com\/pharma\/pfizer-scores-fda-nod-hemophilia-b-gene-therapy-will-charge-35m-dose\" target=\"_blank\">\n                                    Read more                                <\/a>\n                            <\/p>\n                                            <\/div>\n                <\/div>\n            <\/article>\n                        <article class=\"gridpost-card carbon\">\n                <div class=\"card-inner\">\n                                            <a class=\"thumb\" href=\"https:\/\/www.biospace.com\/fda-greenlights-bms-j-and-j-car-t-therapies-for-earlier-multiple-myeloma-treatment\" target=\"_blank\">\n                            <img decoding=\"async\" width=\"1000\" height=\"563\" src=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/download-1.webp\" class=\"attachment-large size-large wp-post-image\" alt=\"\" loading=\"lazy\" srcset=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/download-1.webp 1000w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/download-1-300x169.webp 300w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/download-1-768x432.webp 768w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/download-1-321x180.webp 321w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/download-1-1024x576.webp 1024w\" sizes=\"auto, (max-width: 1000px) 100vw, 1000px\" \/>                        <\/a>\n                                        <div class=\"gridpost-body\">\n                        <h3 class=\"tbp_title\">\n                            <a href=\"https:\/\/www.biospace.com\/fda-greenlights-bms-j-and-j-car-t-therapies-for-earlier-multiple-myeloma-treatment\" target=\"_blank\">FDA Greenlights BMS, J&#038;J CAR-T Therapies<\/a>\n                        <\/h3>\n                                                    <p class=\"excerpt\">The approvals, third line for BMS and 2seventy Bio\u2019s Abecma and second line for J&amp;J and Legend Biotech\u2019s Carvykti, represent a new class of&hellip;<\/p>\n                        \n                                                    <p>\n                                <a class=\"read-more\" href=\"https:\/\/www.biospace.com\/fda-greenlights-bms-j-and-j-car-t-therapies-for-earlier-multiple-myeloma-treatment\" target=\"_blank\">\n                                    Read more                                <\/a>\n                            <\/p>\n                                            <\/div>\n                <\/div>\n            <\/article>\n                        <article class=\"gridpost-card carbon\">\n                <div class=\"card-inner\">\n                                            <a class=\"thumb\" href=\"https:\/\/www.biospace.com\/orchard-therapeutics-receives-fda-approval-of-lenmeldy-atidarsagene-autotemcel-the-only-therapy-for-eligible-children-with-early-onset-metachromatic-leukodystrophy-in-the-u-s\" target=\"_blank\">\n                            <img decoding=\"async\" width=\"400\" height=\"300\" src=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/11_CarbonNews_Orchard.png\" class=\"attachment-large size-large wp-post-image\" alt=\"\" loading=\"lazy\" srcset=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/11_CarbonNews_Orchard.png 400w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/11_CarbonNews_Orchard-300x225.png 300w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/11_CarbonNews_Orchard-1024x768.png 1024w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/11_CarbonNews_Orchard-321x240.png 321w\" sizes=\"auto, (max-width: 400px) 100vw, 400px\" \/>                        <\/a>\n                                        <div class=\"gridpost-body\">\n                        <h3 class=\"tbp_title\">\n                            <a href=\"https:\/\/www.biospace.com\/orchard-therapeutics-receives-fda-approval-of-lenmeldy-atidarsagene-autotemcel-the-only-therapy-for-eligible-children-with-early-onset-metachromatic-leukodystrophy-in-the-u-s\" target=\"_blank\">Orchard Therapeutics Outlines U.S. Launch Plans For Lenmeldy<\/a>\n                        <\/h3>\n                                                    <p class=\"excerpt\">Orchard Therapeutics announced the U.S. Food and Drug Administration has approved Lenmeldy\u2122, formerly known as OTL-200, for the treatment of children with pre-symptomatic late&hellip;<\/p>\n                        \n                                                    <p>\n                                <a class=\"read-more\" href=\"https:\/\/www.biospace.com\/orchard-therapeutics-receives-fda-approval-of-lenmeldy-atidarsagene-autotemcel-the-only-therapy-for-eligible-children-with-early-onset-metachromatic-leukodystrophy-in-the-u-s\" target=\"_blank\">\n                                    Read more                                <\/a>\n                            <\/p>\n                                            <\/div>\n                <\/div>\n            <\/article>\n                        <article class=\"gridpost-card carbon\">\n                <div class=\"card-inner\">\n                                            <a class=\"thumb\" href=\"https:\/\/news.bms.com\/news\/details\/2024\/U.S.-FDA-Approves-Bristol-Myers-Squibbs-Breyanzi--as-the-First-and-Only-CAR-T-Cell-Therapy-for-Adults-with-Relapsed-or-Refractory-Chronic-Lymphocytic-Leukemia-CLL-or-Small-Lymphocytic-Lymphoma-SLL\/default.aspx\" target=\"_blank\">\n                            <img decoding=\"async\" width=\"480\" height=\"320\" src=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/2009-US-2300374_Breyanzi_Product_Image_for_CLL_FDA_Approval_FINAL.jpg\" class=\"attachment-large size-large wp-post-image\" alt=\"\" loading=\"lazy\" srcset=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/2009-US-2300374_Breyanzi_Product_Image_for_CLL_FDA_Approval_FINAL.jpg 480w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/2009-US-2300374_Breyanzi_Product_Image_for_CLL_FDA_Approval_FINAL-300x200.jpg 300w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/2009-US-2300374_Breyanzi_Product_Image_for_CLL_FDA_Approval_FINAL-1024x682.jpg 1024w, https:\/\/novacore.com\/carbon\/wp-content\/uploads\/2025\/11\/2009-US-2300374_Breyanzi_Product_Image_for_CLL_FDA_Approval_FINAL-321x214.jpg 321w\" sizes=\"auto, (max-width: 480px) 100vw, 480px\" \/>                        <\/a>\n                                        <div class=\"gridpost-body\">\n                        <h3 class=\"tbp_title\">\n                            <a href=\"https:\/\/news.bms.com\/news\/details\/2024\/U.S.-FDA-Approves-Bristol-Myers-Squibbs-Breyanzi--as-the-First-and-Only-CAR-T-Cell-Therapy-for-Adults-with-Relapsed-or-Refractory-Chronic-Lymphocytic-Leukemia-CLL-or-Small-Lymphocytic-Lymphoma-SLL\/default.aspx\" target=\"_blank\">U.S. FDA Approves Bristol Myers Squibb\u2019s Breyanzi<\/a>\n                        <\/h3>\n                                                    <p class=\"excerpt\">U.S. FDA Approves Bristol Myers Squibb\u2019s Breyanzi \u00ae as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Chronic&hellip;<\/p>\n                        \n                                                    <p>\n                                <a class=\"read-more\" href=\"https:\/\/news.bms.com\/news\/details\/2024\/U.S.-FDA-Approves-Bristol-Myers-Squibbs-Breyanzi--as-the-First-and-Only-CAR-T-Cell-Therapy-for-Adults-with-Relapsed-or-Refractory-Chronic-Lymphocytic-Leukemia-CLL-or-Small-Lymphocytic-Lymphoma-SLL\/default.aspx\" target=\"_blank\">\n                                    Read more                                <\/a>\n                            <\/p>\n                                            <\/div>\n                <\/div>\n            <\/article>\n                        <\/div>\n\n            \n                <nav class=\"ngp-pagination pagenav tf_clear tf_box tf_textr tf_clearfix\"><span aria-current=\"page\" class=\"page-numbers current\">1<\/span><a class=\"number\" class=\"page-numbers\" href=\"https:\/\/novacore.com\/carbon\/wp-json\/wp\/v2\/pages\/1089\/page\/2\/\">2<\/a><a class=\"number\" class=\"page-numbers\" href=\"https:\/\/novacore.com\/carbon\/wp-json\/wp\/v2\/pages\/1089\/page\/3\/\">3<\/a><a href=\"https:\/\/novacore.com\/carbon\/wp-json\/wp\/v2\/pages\/1089\/page\/2\/\" class=\"number nextp\">\u203a<\/a><a href=\"https:\/\/novacore.com\/carbon\/wp-json\/wp\/v2\/pages\/1089\/page\/3\/\" title=\"\u00bb\" class=\"number lastp\">\u00bb<\/a><\/nav>\n\n            \n        <\/div>\n\n            <\/div>\n<\/div>\n<!-- \/module plain text -->        <\/div>\n                        <\/div>\n        <\/div>\n                        <div  data-css_id=\"ytpf462\" data-lazy=\"1\" class=\"module_row themify_builder_row fullwidth tb_ytpf462 tf_w\">\n                        <div class=\"row_inner col_align_top tb_col_count_1 tf_box tf_rel\">\n                        <div  data-lazy=\"1\" class=\"module_column tb-column col-full tb_8lcq462 first\">\n                    <!-- module text -->\n<div  class=\"module module-text tb_0xwu462   \" data-lazy=\"1\">\n        <div  class=\"tb_text_wrap\">\n        <p style=\"text-align: center;\">Carbon Stop Loss Solutions services are provided by IOA Re, LLC (NPN #2006648) and Sequoia Reinsurance Services, LLC (NPN #18853752). Rockport Benefits operates as a division of IOA Re, LLC.<\/p>    <\/div>\n<\/div>\n<!-- \/module text -->        <\/div>\n                        <\/div>\n        <\/div>\n                        <div  data-lazy=\"1\" class=\"module_row themify_builder_row tb_tg2w462 tf_w\">\n            <span  class=\"builder_row_cover tf_abs\" data-lazy=\"1\"><\/span>            <div class=\"row_inner col_align_top tb_col_count_1 tf_box tf_rel\">\n                        <div  data-lazy=\"1\" class=\"module_column tb-column col-full tb_nean462 first\">\n                    <!-- module text -->\n<div  class=\"module module-text tb_xbkr462   \" data-lazy=\"1\">\n        <div  class=\"tb_text_wrap\">\n        <h2 style=\"text-align: center;\">Interested in learning more?<\/h2>\n    <\/div>\n<\/div>\n<!-- \/module text -->        <div  data-lazy=\"1\" class=\"module_subrow themify_builder_sub_row tf_w col_align_top tb_col_count_1 tb_ppna462\">\n                <div  data-lazy=\"1\" class=\"module_column sub_column col-full tb_k0fe462 first\">\n                    <!-- module button pro -->\n<div  id=\"tb_tjlt462\" class=\"module module-button tb_tjlt462 button-link-external  tb_gs1084691 transparent\" data-lazy=\"1\">\n\t\n    <a  class=\"ui builder_button transparent rounded\" href=\"\/carbon\/contact-us\/\">\n\t\t\t\t<span>Contact us<\/span>\n    <\/a>\n\n\t\n\t<\/div>\n<!-- \/module button pro -->\n        <\/div>\n                    <\/div>\n                <\/div>\n                        <\/div>\n        <\/div>\n        <\/div>\n<!--\/themify_builder_content-->","protected":false},"excerpt":{"rendered":"<p>News Get the latest market insights Stay up to date with Carbon\u2019s expert perspectives, company news and the latest on the pipeline of novel cell and gene therapies that present profound financial implications for payors. Follow us on\u00a0LinkedIn\u00a0for ongoing updates. Carbon Stop Loss Solutions services are provided by IOA Re, LLC (NPN #2006648) and Sequoia [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":1429,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-1089","page","type-page","status-publish","has-post-thumbnail","hentry","has-post-title","has-post-date","has-post-category","has-post-tag","has-post-comment","has-post-author",""],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News &amp; Updates - Stop-Loss &amp; Reinsurance | Carbon<\/title>\n<meta name=\"description\" content=\"Stay up to date with Carbon\u2019s expert perspectives and news about the pipeline of cell and gene therapies that carry large financial implications for payors.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novacore.com\/carbon\/news\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News &amp; Updates - Stop-Loss &amp; Reinsurance | Carbon\" \/>\n<meta property=\"og:description\" content=\"Stay up to date with Carbon\u2019s expert perspectives and news about the pipeline of cell and gene therapies that carry large financial implications for payors.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novacore.com\/carbon\/news\/\" \/>\n<meta property=\"og:site_name\" content=\"Carbon Stop Loss Solutions\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-09T03:43:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/sites\/78\/2025\/12\/Carbon_FeatureImage.png\" \/>\n\t<meta property=\"og:image:width\" content=\"500\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/novacore.com\\\/carbon\\\/news\\\/\",\"url\":\"https:\\\/\\\/novacore.com\\\/carbon\\\/news\\\/\",\"name\":\"News & Updates - Stop-Loss & Reinsurance | Carbon\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/novacore.com\\\/carbon\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/novacore.com\\\/carbon\\\/news\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/novacore.com\\\/carbon\\\/news\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/novacore.com\\\/carbon\\\/wp-content\\\/uploads\\\/sites\\\/78\\\/2025\\\/12\\\/Carbon_FeatureImage.png\",\"datePublished\":\"2025-11-14T15:21:13+00:00\",\"dateModified\":\"2025-12-09T03:43:20+00:00\",\"description\":\"Stay up to date with Carbon\u2019s expert perspectives and news about the pipeline of cell and gene therapies that carry large financial implications for payors.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/novacore.com\\\/carbon\\\/news\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/novacore.com\\\/carbon\\\/news\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/novacore.com\\\/carbon\\\/news\\\/#primaryimage\",\"url\":\"https:\\\/\\\/novacore.com\\\/carbon\\\/wp-content\\\/uploads\\\/sites\\\/78\\\/2025\\\/12\\\/Carbon_FeatureImage.png\",\"contentUrl\":\"https:\\\/\\\/novacore.com\\\/carbon\\\/wp-content\\\/uploads\\\/sites\\\/78\\\/2025\\\/12\\\/Carbon_FeatureImage.png\",\"width\":500,\"height\":500,\"caption\":\"Carbon logo\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/novacore.com\\\/carbon\\\/news\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/novacore.com\\\/carbon\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/novacore.com\\\/carbon\\\/#website\",\"url\":\"https:\\\/\\\/novacore.com\\\/carbon\\\/\",\"name\":\"Carbon Stop Loss Solutions\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/novacore.com\\\/carbon\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"News & Updates - Stop-Loss & Reinsurance | Carbon","description":"Stay up to date with Carbon\u2019s expert perspectives and news about the pipeline of cell and gene therapies that carry large financial implications for payors.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novacore.com\/carbon\/news\/","og_locale":"en_US","og_type":"article","og_title":"News & Updates - Stop-Loss & Reinsurance | Carbon","og_description":"Stay up to date with Carbon\u2019s expert perspectives and news about the pipeline of cell and gene therapies that carry large financial implications for payors.","og_url":"https:\/\/novacore.com\/carbon\/news\/","og_site_name":"Carbon Stop Loss Solutions","article_modified_time":"2025-12-09T03:43:20+00:00","og_image":[{"width":500,"height":500,"url":"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/sites\/78\/2025\/12\/Carbon_FeatureImage.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/novacore.com\/carbon\/news\/","url":"https:\/\/novacore.com\/carbon\/news\/","name":"News & Updates - Stop-Loss & Reinsurance | Carbon","isPartOf":{"@id":"https:\/\/novacore.com\/carbon\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novacore.com\/carbon\/news\/#primaryimage"},"image":{"@id":"https:\/\/novacore.com\/carbon\/news\/#primaryimage"},"thumbnailUrl":"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/sites\/78\/2025\/12\/Carbon_FeatureImage.png","datePublished":"2025-11-14T15:21:13+00:00","dateModified":"2025-12-09T03:43:20+00:00","description":"Stay up to date with Carbon\u2019s expert perspectives and news about the pipeline of cell and gene therapies that carry large financial implications for payors.","breadcrumb":{"@id":"https:\/\/novacore.com\/carbon\/news\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novacore.com\/carbon\/news\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/novacore.com\/carbon\/news\/#primaryimage","url":"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/sites\/78\/2025\/12\/Carbon_FeatureImage.png","contentUrl":"https:\/\/novacore.com\/carbon\/wp-content\/uploads\/sites\/78\/2025\/12\/Carbon_FeatureImage.png","width":500,"height":500,"caption":"Carbon logo"},{"@type":"BreadcrumbList","@id":"https:\/\/novacore.com\/carbon\/news\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/novacore.com\/carbon\/"},{"@type":"ListItem","position":2,"name":"News"}]},{"@type":"WebSite","@id":"https:\/\/novacore.com\/carbon\/#website","url":"https:\/\/novacore.com\/carbon\/","name":"Carbon Stop Loss Solutions","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/novacore.com\/carbon\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/novacore.com\/carbon\/wp-json\/wp\/v2\/pages\/1089","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/novacore.com\/carbon\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/novacore.com\/carbon\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/novacore.com\/carbon\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/novacore.com\/carbon\/wp-json\/wp\/v2\/comments?post=1089"}],"version-history":[{"count":0,"href":"https:\/\/novacore.com\/carbon\/wp-json\/wp\/v2\/pages\/1089\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/novacore.com\/carbon\/wp-json\/wp\/v2\/media\/1429"}],"wp:attachment":[{"href":"https:\/\/novacore.com\/carbon\/wp-json\/wp\/v2\/media?parent=1089"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}